Seeking Alpha

Circassia raises £191M in largest London biotech IPO in 19 years

  • Could London could be about to catch the biotech bug that has infected the U.S.? Allergy drug firm Circassia has raised £191M in an IPO on the London Stock Exchange after selling shares for 310 pence each at a market cap of £581M.
  • The U.K. biotech sector hopes the listing will open the way for a new wave of IPOs, as has occurred in the U.S. The last major offering in the industry in London before Circassia's was ten years ago; the latest IPO is also the largest biotech listing since at least 1995.
  • However, investors are wary after the dismal performance of other biotech plays.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs